| SH2B3 inactivation through CN-LOH 12q is uniquely associated with B-cell precursor ALL with iAMP21 or other chromosome 21 gain PB Sinclair, S Ryan, M Bashton, S Hollern, R Hanna, M Case, ... Leukemia 33 (8), 1881-1894, 2019 | 28 | 2019 |
| Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial C Schwab, RE Cranston, SL Ryan, E Butler, E Winterman, Z Hawking, ... Leukemia 37 (3), 529-538, 2023 | 16 | 2023 |
| Genetic characterisation of childhood B‐other‐acute lymphoblastic leukaemia in UK patients by fluorescence in situ hybridisation and Multiplex Ligation … CJ Schwab, D Murdy, E Butler, A Enshaei, E Winterman, RE Cranston, ... British journal of haematology 196 (3), 753-763, 2022 | 11 | 2022 |
| Investigating the biology of atypical teratoid/rhabdoid tumors by whole genome CRISPR/Cas9 screening MP Selby, MA Finetti, M Bashton, RE Cranston, Y Grabovska, ... Cancer Research 77 (13_Supplement), 408-408, 2017 | 1 | 2017 |
| Whole Genome Sequencing for Detection of Prognostically Relevant Genetic Abnormalities in Paediatric Acute Myeloid Leukaemia C Schwab, RE Cranston, E Winterman, J Jovanovic, Z Kingsbury, ... Blood 140 (Supplement 1), 3204-3205, 2022 | | 2022 |
| PS921 INACTIVATION OF SH2B3 THROUGH CN-LOH 12Q IS UNIQUELY ASSOCIATED WITH B-CELL PRECURSOR ALL WITH IAMP21 OR OTHER CHROMOSOME 21 GAIN P Sinclair, S Ryan, M Bashton, S Hollern, R Hanna, M Case, E Schwalbe, ... HemaSphere 3 (S1), 415, 2019 | | 2019 |
| A Genome-Wide CRISPR Screen Implicates MYC Dysregulation in TCF3-PBX1 B-ALL RE Cranston, PB Sinclair, M Bashton, MP Selby, CJ Harrison Blood 132, 3915, 2018 | | 2018 |
| INVESTIGATING THE BIOLOGY OF ATYPICAL TERATOID/RHABDOID TUMORS BY WHOLE GENOME CRISPR/CAS9 SCREENING MP Selby, MA Finetti, M Bashton, RE Cranston, A Del-Carpio-Pons, ... NEURO-ONCOLOGY 18, 5-5, 2016 | | 2016 |
| AT-18INVESTIGATING THE BIOLOGY OF ATYPICAL TERATOID/RHABDOID TUMORS BY WHOLE GENOME CRISPR/CAS9 SCREENING MP Selby, MA Finetti, M Bashton, RE Cranston, A Del-Carpio-Pons, ... Neuro-Oncology 18 (Suppl 3), iii5, 2016 | | 2016 |
| Integrated pathway analysis of malignant rhabdoid tumour identifies key SMARCB1-pathways and therapeutic opportunities MA Finetti, MP Selby, ADC Pons, JP Wong, M Bashton, RE Cranston, ... European Journal of Cancer 1 (69), S51, 2016 | | 2016 |
Matthew BashtonThe Hub for Biotechnology in the Built Environment, Faculty of Health and Life Sciences, NorthumbriaVerified email at northumbria.ac.uk
